PRESS RELEASE
News
-
-
-
-
PRESS RELEASE
Two Labs Launches Sunshine Transparency and Aggregate Spend Offering to Provide Transparency Reporting and Compliance Support to the Pharma Industry
Two Labs, an Envision Pharma Company, launches Sunshine Transparency and Aggregate Spend service to help pharmaceutical manufacturers with regulatory compliance and transparency in financial relationships with healthcare professionals and organizations -
PRESS RELEASE
Li-Metal Announces Completion of Concept Study for a 1,000-Tonne Commercial-Scale Lithium Metal Plant
Li-Metal Corp. announces encouraging results from an engineering study regarding the potential commercial deployment of its C2M technology. The study indicates favorable plant-level economics, reduced GHG emissions, and partnerships with IRA-compliant lithium carbonate producers and battery OEMs -
-
PRESS RELEASE
Signal Gold Outlines Near-Term 2024 Priorities, Building on Recent Success at the Goldboro Project
Signal Gold Inc. outlines 2024 priorities for the Goldboro Project, including continued growth exploration and pursuing final permits. Company maintains strong financial position and aims to build exceptional social license -
PRESS RELEASE
Sun Peak Metals Provides Corporate Update - Exploration Work Expected To Resume on Shire Project
Sun Peak Metals Corp. (TSXV:PEAK)(OTCQB:SUNPF) prepares to resume exploration activities on the Shire Project, Ethiopia. The Company will recommence work on three exploration licenses in the first half of 2024, including drilling for copper-gold VMS targets -
PRESS RELEASE
OHB DC to build new UHF control station for satellite communications for the German armed forces
OHB SE's subsidiary OHB DC has been awarded a contract to build a new UHF control station for satellite communications for the German armed forces. The construction will result in a more powerful control station to ensure communication availability -
PRESS RELEASE
Transaction Update
Arix Bioscience PLC (ARIX) announces the recommended all-share acquisition of its assets by RTW Biotech Opportunities Ltd. The timetable for the scheme remains as set out in the shareholder circular, with the second general meeting to be held on 12 February 2024 in London, United Kingdom
